Maiwald at the LSPN North America Spring 2025 in Boston, May 6-7, 2025

Maiwald is joining one of the most influential IP conference in the life sciences

The 7th Annual LSPN North America–Spring Conference is an important destination for cutting-edge insights into intellectual property challenges in pharmaceutical, biotechnology, and medical technology industries.

We are excited to announce that Maiwald is a gold sponsor to the upcoming Life Sciences Patent Network North America Spring 2025 conference in Boston on May 6-7 – a unique opportunity to network, gain valuable insights into the latest trends, challenges, and best practices shaping the future of life sciences innovation.

Don’t miss the chance to participate in the Panel discussion on day 1 of the event with Dr. Eva Ehlich with the title: The Transparency Tightrope: Balancing Innovation, Regulation, and IP Protection in a New Era.

In the ever-evolving landscape of life sciences, a new challenge has emerged at the intersection of innovation, regulation, and intellectual property protection. This panel discussion will explore the far-reaching implications of increased transparency requirements in clinical trials and their impact on the global patent system.  Recent regulatory changes, particularly in Europe, have ushered in an era of enhanced transparency in clinical trials. While these changes aim to foster scientific progress and public trust, they create significant hurdles for companies seeking to protect their IP. The requirement to disclose clinical trial information early in the development process can potentially undermine patent rights, shaping patent filing strategy and timelines globally.

Furthermore, don’t miss the chance to join Dr. Anja Fux & Dr. Sun Jin Lee for a Roundtable discussion on the topic: From Protection to Prevention: Patenting Antibodies and Vaccines in Europe (EPO and UPC).